There are two arms in our trial, DCB group, BMS group.The investigators are going to investigate the safety and efficacy of all groups at 6 months and 12 months.
Study Type
OBSERVATIONAL
Enrollment
95
Orchid and Dahlia DCB
any type of bare metal stent
Beijing Anzhen hospital
Beijing, China
The rockets army general hospital
Beijing, China
The first affiliated hospital of Dalian medical university
Dalian, China
The first affiliated hospital of Harbin medical university
Harbin, China
Incidence of vascular death,non-fatal myocardial and non-fatal stroke in 12 months
vascular death,non-fatal myocardial and non-fatal stroke diagnosed by specialist physician
Time frame: 12 months
lumen loss at 6 months
lumen loss measured by doppler untrasound
Time frame: 6 months
lumen loss at 12 months
lumen loss measured by doppler untrasound
Time frame: 12 months
restenosis at 6 months
restenosis was assessed by doppler untrasound
Time frame: 6 months
restenosis at 12 months
restenosis was assessed by doppler untrasound
Time frame: 12 months
traget lesion revascularizition at 12 months
traget lesion revascularizition including envascular intervention and Surgery
Time frame: 12 months
Incidence of safety events including vascular death,non-fatal myocardial infarction, or non-fatal stroke in 30 days
safety events including vascular death,non-fatal myocardial infarction, or non-fatal stroke diagnosed by investigators within 30 days after start of the treatment
Time frame: 30 days
stent fracture rate at 12 months
stent fracture was assessed by DSA
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The first hospital of Jilin university
Jilin, China
Shengjing Hosptal of china medical university
Shenyang, China
Henan provincial peoples hospital
Zhengzhou, China
The first hospital of zhengzhou university
Zhengzhou, China
Zhengzhou center hospital
Zhengzhou, China